Abstract: A pharmaceutical composition for the therapeutical treatment of anxiety and neurodystonic states characterized by combining an anxiolytic belonging to the class of the benzodiazepines and a beta-adrenergic receptor blocking agent, in which said benzodiazepinic anxiolytic is 3-N,N-dimethylcarbamoyloxy-1-methyl, 5-phenyl, 7-chloro, 1,3-dihydro-2H-1,4-benzodiazepin-2-one- and said beta-adrenergic receptor blocking agent is 1-(0-methoxyphenoxy)-3-isopropylamino-propan-2-olo.
Type:
Grant
Filed:
August 21, 1978
Date of Patent:
February 26, 1980
Assignee:
Simes Societa Italiana Medicinali e Sintatici S.p.A.